These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23587153)
1. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153 [TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital. Oqal MK; Mustafa KN; Irshaid YM Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637 [TBL] [Abstract][Full Text] [Related]
3. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis. Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365 [TBL] [Abstract][Full Text] [Related]
4. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers. Jarrar YB; Ismail S; Irshaid YM Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375 [TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844 [TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
7. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population. Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378 [TBL] [Abstract][Full Text] [Related]
8. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus. Mrozikiewicz PM; Drakoulis N; Roots I Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):626-34. PubMed ID: 7995004 [TBL] [Abstract][Full Text] [Related]
9. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453 [TBL] [Abstract][Full Text] [Related]
10. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population. Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284 [TBL] [Abstract][Full Text] [Related]
11. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164 [TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714 [TBL] [Abstract][Full Text] [Related]
14. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals. Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701 [TBL] [Abstract][Full Text] [Related]
15. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism. Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413 [TBL] [Abstract][Full Text] [Related]
16. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients]. An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817 [TBL] [Abstract][Full Text] [Related]
17. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility. Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403 [TBL] [Abstract][Full Text] [Related]
18. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis. Skretkowicz K; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Rychlik-Sych M; Sysa-Jedrzejowska A Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348 [TBL] [Abstract][Full Text] [Related]
19. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes. Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877 [TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping]. Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]